Effects of LAMA/LABA Alone and in Combination on Cardiac Safety

被引：2

作者：

Andreas, Stefan ^{[1
,2
,3
]}

机构：

[1] Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany

[2] LungClin Immenhausen, Immenhausen, Germany

[3] German Ctr Lung Res DZL, Marburg, Germany

来源：

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020年 / 15卷

关键词：

OBSTRUCTIVE PULMONARY-DISEASE; COPD; TIOTROPIUM; RESPIMAT(R); MORTALITY;

D O I：

10.2147/COPD.S246356

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：1931 / 1933

页数：3

共 23 条

[1]

Andreas S, 2020, INT J CHRON OBSTRUCT

[2] Effect of long-acting β2-agonists olodaterol and formoterol on heart rate and blood pressure in chronic obstructive pulmonary disease patients [J].

Andreas, Stefan ;

Bothner, Ulrich ;

Trampisch, Matthias ;

Haensel, Michaela ;

Buhl, Roland ;

Alter, Peter .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 52 :1-6

[3] Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease [J].

Buhl, Roland ;

Magder, Sheldon ;

Bothner, Ulrich ;

Tetzlaff, Kay ;

Voss, Florian ;

Loaiza, Lazaro ;

Vogelmeier, Claus F. ;

McGarvey, Lorcan .

RESPIRATORY MEDICINE, 2017, 122 :58-66

[4] Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4) [J].

Buhl, Roland ;

Maltais, Francois ;

Abrahams, Roger ;

Bjermer, Leif ;

Derom, Eric ;

Ferguson, Gary ;

Flezar, Matjaz ;

Hebert, Jacques ;

McGarvey, Lorcan ;

Pizzichini, Emilio ;

Reid, Jim ;

Veale, Antony ;

Groenke, Lars ;

Hamilton, Alan ;

Korducki, Lawrence ;

Tetzlaff, Kay ;

Waitere-Wijker, Stella ;

Watz, Henrik ;

Bateman, Eric .

EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (04) :969-979

[5] Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia [J].

Cazzola, M ;

Imperatore, F ;

Salzillo, A ;

Di Perna, F ;

Calderaro, F ;

Imperatore, A ;

Matera, MG .

CHEST, 1998, 114 (02) :411-415

[6] Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care [J].

Feary, Johanna R. ;

Rodrigues, Laura C. ;

Smith, Christopher J. ;

Hubbard, Richard B. ;

Gibson, Jack E. .

THORAX, 2010, 65 (11) :956-962

[7] Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis [J].

Fuhrman, C. ;

Jougla, E. ;

Nicolau, J. ;

Eilstein, D. ;

Delmas, M-C .

THORAX, 2006, 61 (11) :930-934

[8]

Global Initiative for Chronic Obstructive Lung Disease, 2019, GLOB STRAT DIAGN MAN

[9] Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis [J].

Halpin, David M. G. ;

Dahl, Ronald ;

Hallmann, Christoph ;

Mueller, Achim ;

Tashkin, Donald .

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 :239-259

[10] Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD [J].

Han, MeiLan K. ;

Ray, Riju ;

Foo, Jason ;

Morel, Chaienna ;

Hahn, Beth .

NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2018, 28

← 1 2 3 →